サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1782982

変形性関節症注射剤の世界市場

Osteoarthritis Injectables

出版日
ページ情報
英文 379 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.46円
変形性関節症注射剤の世界市場
出版日: 2025年08月04日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 379 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

変形性関節症注射剤の世界市場は2030年までに100億米ドルに達する見込み

2024年に75億米ドルと推定される変形性関節症注射剤の世界市場は、2024年から2030年にかけてCAGR 5.0％で成長し、2030年には100億米ドルに達すると予測されます。本レポートで分析したセグメントの一つであるヒアルロン酸注射は、CAGR 4.1％を記録し、分析期間終了時には25億米ドルに達すると予測されます。副腎皮質ステロイド注射セグメントの成長率は、分析期間中CAGR 4.0％と推定されます。

米国市場は20億米ドルと推定、中国はCAGR 7.8％で成長予測

米国の変形性関節症注射剤市場は2024年に20億米ドルと推定されます。世界第2位の経済大国である中国は、2024～2030年の分析期間においてCAGR 7.8％をたどり、2030年までに20億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.5％と4.9％と予測されています。欧州では、ドイツがCAGR 3.2%で成長すると予測されています。

世界の変形性関節症注射剤市場- 主要動向と促進要因のまとめ

変形性関節症注射剤は疼痛管理と関節ケアをどのように変革しているか？

変形性関節症注射剤市場は、関節の疼痛や炎症を管理するための非外科的治療オプションがますます好まれるようになるにつれて、大きな牽引力となっています。変形性関節症（OA）が世界中で数百万人に影響を及ぼしている中、患者やヘルスケアプロバイダーは、人工関節置換術を遅らせたり回避したりするために、低侵襲な解決策を求めています。副腎皮質ステロイド、ヒアルロン酸、多血小板血漿（PRP）、幹細胞を用いた治療などの注射療法は、的を絞った痛みの緩和、関節可動域の改善、軟骨の健康増進をもたらす能力により、広く採用されています。世界の人口の高齢化と肥満率の上昇は、OAの2つの主要な危険因子であり、経口鎮痛剤に伴う副作用を伴わずに長期的な緩和を提供する効果的な注射剤への需要をさらに高めています。

変形性関節症の治療において、新たな生物学的療法と再生療法はどのような役割を果たすのか？

変形性関節症治療の情勢は、生物学的注射剤や再生医療アプローチの採用の増加とともに変化しています。患者自身の血液由来の成長因子を利用するPRP療法は、従来のステロイド注射に代わる有望な治療法として人気を博しています。また、幹細胞を用いた治療法も台頭してきており、単なる対症療法ではなく、軟骨の再生と長期的な疾患改善の可能性を提供しています。さらに、架橋療法や併用療法を含むヒアルロン酸製剤の進歩は、関節内補充療法の耐久性と有効性を向上させています。炎症経路を標的とする遺伝子治療やモノクローナル抗体の研究も進行中であり、OA管理に革命をもたらす次世代の注射治療が期待されています。

変形性関節症注射剤の普及を阻む課題は何か？

その有効性にもかかわらず、変形性関節症注射剤の普及にはいくつかの障壁が存在します。高い治療費、特に生物学的製剤や幹細胞を用いた治療には大きな懸念が残り、多くの患者の治療へのアクセスを制限しています。さらに、臨床結果のばらつきや、新しい再生治療の標準化されたプロトコルの欠如は、規制当局の承認や医師の採用における課題となっています。副腎皮質ステロイドのような一部の注射療法は、長期間の使用による軟骨の劣化を含む潜在的な副作用と関連しており、慎重な処方につながっています。しかし、現在進行中の調査と臨床試験により、これらの限界に対処し、製剤を改良し、投与レジメンを最適化することで、治療の有効性と安全性を高めようとしています。

変形性関節症注射剤市場の成長を後押ししているのは？

変形性関節症注射剤市場の成長は、変形性関節症の有病率の増加、低侵襲治療に対する需要の高まり、生物学的療法や再生療法の進歩など、いくつかの要因によってもたらされます。外来やオフィス内での処置に対する嗜好の高まりが、外科的介入よりも注射療法の採用を後押ししています。さらに、各国におけるヒアルロン酸やPRP注射を対象とした償還政策の拡大が、市場の成長を支えています。高齢者人口の増加は、新規変形性関節症治療薬の研究開発への投資の増加とともに、市場拡大をさらに加速させています。次世代薬剤の出現

セグメント

注射剤（ヒアルロン酸注射剤、副腎皮質ステロイド注射剤、血小板リッチ血漿注射剤、胎盤組織マトリックス注射剤、アセチルサリチル酸注射剤、その他の注射剤）、解剖学（変形性膝関節症、変形性股関節症、変形性手関節症、その他の解剖学）、エンドユーザー（病院薬局エンドユーザー、小売薬局エンドユーザー、その他のエンドユーザー）

調査対象企業の例

  • AbbVie Inc.
  • Amgen Inc.
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • Bayer AG
  • Bioventus LLC
  • Boehringer Ingelheim International GmbH
  • Ferring Pharmaceuticals Inc.
  • Fidia Farmaceutici S.p.A.
  • Flexion Therapeutics, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Samsung Bioepis Co., Ltd.
  • Sanofi S.A.
  • Seikagaku Corporation
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Zimmer Biomet Holdings, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32455

Global Osteoarthritis Injectables Market to Reach US$10.0 Billion by 2030

The global market for Osteoarthritis Injectables estimated at US$7.5 Billion in the year 2024, is expected to reach US$10.0 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Hyaluronic Acid Injections, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Corticosteroid Injections segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.0 Billion While China is Forecast to Grow at 7.8% CAGR

The Osteoarthritis Injectables market in the U.S. is estimated at US$2.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Osteoarthritis Injectables Market - Key Trends & Drivers Summarized

How Are Osteoarthritis Injectables Transforming Pain Management and Joint Care?

The osteoarthritis injectables market has gained significant traction as non-surgical treatment options for managing joint pain and inflammation become increasingly preferred. With osteoarthritis (OA) affecting millions worldwide, patients and healthcare providers are seeking minimally invasive solutions to delay or avoid joint replacement surgery. Injectable therapies, including corticosteroids, hyaluronic acid, platelet-rich plasma (PRP), and stem cell-based treatments, are being widely adopted due to their ability to provide targeted pain relief, improve joint mobility, and enhance cartilage health. The aging global population and rising obesity rates-two major risk factors for OA-are further fueling the demand for effective injectables that offer prolonged relief without the side effects associated with oral pain medications.

What Role Do Emerging Biologic and Regenerative Therapies Play in Osteoarthritis Treatment?

The landscape of osteoarthritis treatment is shifting with the increasing adoption of biologic injectables and regenerative medicine approaches. PRP therapy, which utilizes the patient's own blood-derived growth factors, has gained popularity as a promising alternative to traditional steroid injections. Stem cell-based therapies are also emerging, offering the potential for cartilage regeneration and long-term disease modification rather than just symptomatic relief. Additionally, advancements in hyaluronic acid formulations, including cross-linked and combination therapies, are improving the durability and efficacy of viscosupplementation. Research into gene therapy and monoclonal antibodies targeting inflammatory pathways is also underway, promising next-generation injectable treatments that could revolutionize OA management.

What Are the Key Challenges Limiting the Adoption of Osteoarthritis Injectables?

Despite their effectiveness, several barriers exist in the widespread adoption of osteoarthritis injectables. High treatment costs, particularly for biologic and stem cell-based therapies, remain a significant concern, limiting accessibility for many patients. Additionally, variability in clinical outcomes and the lack of standardized protocols for emerging regenerative treatments pose challenges for regulatory approval and physician adoption. Some injectable therapies, such as corticosteroids, have been associated with potential side effects, including cartilage degradation with prolonged use, leading to cautious prescribing practices. However, ongoing research and clinical trials are working to address these limitations, refining formulations and optimizing dosing regimens to enhance treatment efficacy and safety.

What’s Fueling the Growth of the Osteoarthritis Injectables Market?

The growth in the osteoarthritis injectables market is driven by several factors, including the increasing prevalence of osteoarthritis, rising demand for minimally invasive treatments, and advancements in biologic and regenerative therapies. The growing preference for outpatient and in-office procedures has boosted the adoption of injectable therapies over surgical interventions. Additionally, the expansion of reimbursement policies covering hyaluronic acid and PRP injections in various countries is supporting market growth. The rising geriatric population, along with increasing investments in R&D for novel osteoarthritis therapeutics, is further accelerating market expansion. The emergence of next-generation

SCOPE OF STUDY:

The report analyzes the Osteoarthritis Injectables market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Injection (Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections, Other Injections); Anatomy (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Other Anatomies); End-Use (Hospital Pharmacies End-Use, Retail Pharmacies End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • AbbVie Inc.
  • Amgen Inc.
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • Bayer AG
  • Bioventus LLC
  • Boehringer Ingelheim International GmbH
  • Ferring Pharmaceuticals Inc.
  • Fidia Farmaceutici S.p.A.
  • Flexion Therapeutics, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Samsung Bioepis Co., Ltd.
  • Sanofi S.A.
  • Seikagaku Corporation
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Osteoarthritis Injectables - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Osteoarthritis in Aging Populations Drives Demand for Injectable Therapies
    • Patient Preference for Non-Surgical Pain Management Expands Use of OA Injectables
    • Surge in Early-Stage OA Diagnoses Spurs Adoption of Viscosupplementation Treatments
    • Expansion of Sports Medicine and Geriatric Care Clinics Enhances Access to Injectables
    • Improved Formulations with Prolonged Efficacy Strengthen Market Viability
    • Rising Demand for Regenerative Alternatives Like PRP and Stem Cell Injections Drives Innovation
    • Shift Toward Combination Therapies Enhances Pain Relief and Joint Function
    • Increased Physician Adoption of Ultrasound-Guided Injections Drives Procedure Accuracy
    • Growth in Outpatient and Ambulatory Injections Streamlines Access and Reduces Cost
    • Development of Novel Viscosupplement Products Expands Competitive Landscape
    • Positive Clinical Trial Outcomes for HA and Biologic Injectables Strengthen Product Confidence
    • Rising Awareness Campaigns and DTC Marketing Expand Patient Willingness to Try Injections
    • Shift in Insurance Coverage and Coding Supports Wider Use of OA Injectable Therapies
    • Growing Popularity of At-Home Rehabilitation Programs Complements Injectable Use
    • Emergence of Personalized OA Treatment Pathways Throws Spotlight on Tailored Injections
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Osteoarthritis Injectables Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Osteoarthritis Injectables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Osteoarthritis Injectables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hyaluronic Acid Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hyaluronic Acid Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Hyaluronic Acid Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Corticosteroid Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Corticosteroid Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Corticosteroid Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Platelet-Rich Plasma Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Platelet-Rich Plasma Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Platelet-Rich Plasma Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Placental Tissue Matrix Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Placental Tissue Matrix Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Placental Tissue Matrix Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Acetylsalicylic Acid Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Acetylsalicylic Acid Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Acetylsalicylic Acid Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Anatomies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Anatomies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Anatomies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Knee Osteoarthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Knee Osteoarthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Knee Osteoarthritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hip Osteoarthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hip Osteoarthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Hip Osteoarthritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hand Osteoarthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hand Osteoarthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Hand Osteoarthritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospital Pharmacies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospital Pharmacies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Hospital Pharmacies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Retail Pharmacies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Retail Pharmacies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Retail Pharmacies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Osteoarthritis Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Osteoarthritis Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Osteoarthritis Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Osteoarthritis Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Osteoarthritis Injectables by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Osteoarthritis Injectables by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Osteoarthritis Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Osteoarthritis Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Osteoarthritis Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Spain 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Russia 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Osteoarthritis Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Osteoarthritis Injectables by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Osteoarthritis Injectables by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Osteoarthritis Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Australia 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Osteoarthritis Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 176: India Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 182: India Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: India 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: South Korea 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Osteoarthritis Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Osteoarthritis Injectables by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Osteoarthritis Injectables by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Latin America 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Argentina 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Brazil 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Mexico 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Osteoarthritis Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Osteoarthritis Injectables by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Osteoarthritis Injectables by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Middle East 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Iran 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Israel 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: UAE 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Osteoarthritis Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Osteoarthritis Injectables by Injection - Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Osteoarthritis Injectables by Injection - Percentage Breakdown of Value Sales for Hyaluronic Acid Injections, Corticosteroid Injections, Platelet-Rich Plasma Injections, Placental Tissue Matrix Injections, Acetylsalicylic Acid Injections and Other Injections for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Osteoarthritis Injectables by Anatomy - Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Osteoarthritis Injectables by Anatomy - Percentage Breakdown of Value Sales for Other Anatomies, Knee Osteoarthritis, Hip Osteoarthritis and Hand Osteoarthritis for the Years 2015, 2025 & 2030
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Osteoarthritis Injectables by End-Use - Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Africa 15-Year Perspective for Osteoarthritis Injectables by End-Use - Percentage Breakdown of Value Sales for Hospital Pharmacies End-Use, Retail Pharmacies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION